openPR Logo
Press release

Lisinopril Market Revenue facts statastics By 2027 | Actavis Elizabeth, Apotex, Aurobindo Pharma

12-30-2021 11:18 AM CET | Health & Medicine

Press release from: QY Research, Inc

Lisinopril Market Revenue facts statastics By 2027 | Actavis

LOS ANGELES, United States: The research study presented in this report offers complete and intelligent analysis of the competition, segmentation, dynamics, and geographical advancement of the global Lisinopril  market. It takes into account the CAGR, value, volume, revenue, production, consumption, sales, manufacturing cost, prices, and other key factors related to the global Lisinopril market. The authors of the report have segmented the global Lisinopril market as per product, application, and region. Segments of the global Lisinopril market are analyzed on the basis of market share, production, consumption, revenue, CAGR, market size, and more factors. The analysts have profiled leading players of the global Lisinopril market, keeping in view their recent developments, market share, sales, revenue, areas covered, product portfolios, and other aspects.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) https://www.qyresearch.com/sample-form/form/4073476/global-lisinopril-market

The report includes company profiling of almost all important players of the global Lisinopril market. The company profiling section offers valuable analysis on strengths and weaknesses, business developments, recent advancements, mergers and acquisitions, expansion plans, global footprint, market presence, and product portfolios of leading market players. This information can be used by players and other market participants to maximize their profitability and streamline their business strategies. Our competitive analysis also includes key information to help new entrants to identify market entry barriers and measure the level of competitiveness in the global Lisinopril market.

Key Players Mentioned in the Global Lisinopril  Market Research Report: Actavis Elizabeth, Apotex, Aurobindo Pharma, Ivax Pharmaceuticals, Lek Pharmaceuticals, Lupin, Mylan Pharmaceuticals, Ranbaxy Pharmaceuticals, Novartis, Teva Pharmaceuticals, Vintage Pharmaceuticals, Watson Laboratories, West Ward Pharmaceutical, Wockhardt, Merck Research Laboratories, Astrazeneca, Alvogen, Hikma, Prinston, Accord Hlthcare, CASI Pharms, Invagen Pharms, SUN Pharm

Global Lisinopril  Market by Type: 2.5mg, 5mg, 10mg, 20mg, 30mg, 40mg

Global Lisinopril  Market by Application: Hospital, Drug Store

The global Lisinopril market is segmented as per type of product, application, and geography. All of the segments of the global Lisinopril market are carefully analyzed based on their market share, CAGR, value and volume growth, and other important factors. The report also provides accurate estimations about the CAGR, revenue, production, sales, and other calculations for the global Lisinopril market. Each regional market is extensively studied in the report to explain why some regions are progressing at a high rate while others at a low rate. We have also provided Porter’s Five Forces and PESTLE analysis for a deeper study on the global Lisinopril market.

Key Questions Answered through the Report

(1) How will the global Lisinopril market perform during the forecast period? What will be the market size in terms of value and volume?

(2) Which segment will drive the global Lisinopril market? Which regional market will show extensive growth in the future? What are the reasons?

(3) How will the Lisinopril market dynamics change because of the impact of future market opportunities, restraints, and drivers?

(4) What are the key strategies adopted by players to sustain themselves in the global Lisinopril market?

(5) How will these strategies influence the Lisinopril market growth and competition?

 

Request for customization in Report:

https://www.qyresearch.com/customize-request/form/4073476/global-lisinopril-market

TOC

1 Lisinopril Market Overview
1.1 Product Overview and Scope of Lisinopril
1.2 Lisinopril Segment by Type
1.2.1 Global Lisinopril Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 2.5mg
1.2.3 5mg
1.2.4 10mg
1.2.5 20mg
1.2.6 30mg
1.2.7 40mg
1.3 Lisinopril Segment by Application
1.3.1 Global Lisinopril Sales Comparison by Application: (2021-2027)
1.3.2 Hospital
1.3.3 Drug Store
1.4 Global Lisinopril Market Size Estimates and Forecasts
1.4.1 Global Lisinopril Revenue 2016-2027
1.4.2 Global Lisinopril Sales 2016-2027
1.4.3 Lisinopril Market Size by Region: 2016 Versus 2021 Versus 2027 2 Lisinopril Market Competition by Manufacturers
2.1 Global Lisinopril Sales Market Share by Manufacturers (2016-2021)
2.2 Global Lisinopril Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Lisinopril Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Lisinopril Manufacturing Sites, Area Served, Product Type
2.5 Lisinopril Market Competitive Situation and Trends
2.5.1 Lisinopril Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Lisinopril Players Market Share by Revenue
2.5.3 Global Lisinopril Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Lisinopril Retrospective Market Scenario by Region
3.1 Global Lisinopril Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Lisinopril Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Lisinopril Market Facts & Figures by Country
3.3.1 North America Lisinopril Sales by Country
3.3.2 North America Lisinopril Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Lisinopril Market Facts & Figures by Country
3.4.1 Europe Lisinopril Sales by Country
3.4.2 Europe Lisinopril Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Lisinopril Market Facts & Figures by Region
3.5.1 Asia Pacific Lisinopril Sales by Region
3.5.2 Asia Pacific Lisinopril Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Lisinopril Market Facts & Figures by Country
3.6.1 Latin America Lisinopril Sales by Country
3.6.2 Latin America Lisinopril Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Lisinopril Market Facts & Figures by Country
3.7.1 Middle East and Africa Lisinopril Sales by Country
3.7.2 Middle East and Africa Lisinopril Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE 4 Global Lisinopril Historic Market Analysis by Type
4.1 Global Lisinopril Sales Market Share by Type (2016-2021)
4.2 Global Lisinopril Revenue Market Share by Type (2016-2021)
4.3 Global Lisinopril Price by Type (2016-2021) 5 Global Lisinopril Historic Market Analysis by Application
5.1 Global Lisinopril Sales Market Share by Application (2016-2021)
5.2 Global Lisinopril Revenue Market Share by Application (2016-2021)
5.3 Global Lisinopril Price by Application (2016-2021) 6 Key Companies Profiled
6.1 Actavis Elizabeth
6.1.1 Actavis Elizabeth Corporation Information
6.1.2 Actavis Elizabeth Description and Business Overview
6.1.3 Actavis Elizabeth Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Actavis Elizabeth Lisinopril Product Portfolio
6.1.5 Actavis Elizabeth Recent Developments/Updates
6.2 Apotex
6.2.1 Apotex Corporation Information
6.2.2 Apotex Description and Business Overview
6.2.3 Apotex Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Apotex Lisinopril Product Portfolio
6.2.5 Apotex Recent Developments/Updates
6.3 Aurobindo Pharma
6.3.1 Aurobindo Pharma Corporation Information
6.3.2 Aurobindo Pharma Description and Business Overview
6.3.3 Aurobindo Pharma Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Aurobindo Pharma Lisinopril Product Portfolio
6.3.5 Aurobindo Pharma Recent Developments/Updates
6.4 Ivax Pharmaceuticals
6.4.1 Ivax Pharmaceuticals Corporation Information
6.4.2 Ivax Pharmaceuticals Description and Business Overview
6.4.3 Ivax Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Ivax Pharmaceuticals Lisinopril Product Portfolio
6.4.5 Ivax Pharmaceuticals Recent Developments/Updates
6.5 Lek Pharmaceuticals
6.5.1 Lek Pharmaceuticals Corporation Information
6.5.2 Lek Pharmaceuticals Description and Business Overview
6.5.3 Lek Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Lek Pharmaceuticals Lisinopril Product Portfolio
6.5.5 Lek Pharmaceuticals Recent Developments/Updates
6.6 Lupin
6.6.1 Lupin Corporation Information
6.6.2 Lupin Description and Business Overview
6.6.3 Lupin Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Lupin Lisinopril Product Portfolio
6.6.5 Lupin Recent Developments/Updates
6.7 Mylan Pharmaceuticals
6.6.1 Mylan Pharmaceuticals Corporation Information
6.6.2 Mylan Pharmaceuticals Description and Business Overview
6.6.3 Mylan Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Mylan Pharmaceuticals Lisinopril Product Portfolio
6.7.5 Mylan Pharmaceuticals Recent Developments/Updates
6.8 Ranbaxy Pharmaceuticals
6.8.1 Ranbaxy Pharmaceuticals Corporation Information
6.8.2 Ranbaxy Pharmaceuticals Description and Business Overview
6.8.3 Ranbaxy Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Ranbaxy Pharmaceuticals Lisinopril Product Portfolio
6.8.5 Ranbaxy Pharmaceuticals Recent Developments/Updates
6.9 Novartis
6.9.1 Novartis Corporation Information
6.9.2 Novartis Description and Business Overview
6.9.3 Novartis Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Novartis Lisinopril Product Portfolio
6.9.5 Novartis Recent Developments/Updates
6.10 Teva Pharmaceuticals
6.10.1 Teva Pharmaceuticals Corporation Information
6.10.2 Teva Pharmaceuticals Description and Business Overview
6.10.3 Teva Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Teva Pharmaceuticals Lisinopril Product Portfolio
6.10.5 Teva Pharmaceuticals Recent Developments/Updates
6.11 Vintage Pharmaceuticals
6.11.1 Vintage Pharmaceuticals Corporation Information
6.11.2 Vintage Pharmaceuticals Lisinopril Description and Business Overview
6.11.3 Vintage Pharmaceuticals Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Vintage Pharmaceuticals Lisinopril Product Portfolio
6.11.5 Vintage Pharmaceuticals Recent Developments/Updates
6.12 Watson Laboratories
6.12.1 Watson Laboratories Corporation Information
6.12.2 Watson Laboratories Lisinopril Description and Business Overview
6.12.3 Watson Laboratories Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Watson Laboratories Lisinopril Product Portfolio
6.12.5 Watson Laboratories Recent Developments/Updates
6.13 West Ward Pharmaceutical
6.13.1 West Ward Pharmaceutical Corporation Information
6.13.2 West Ward Pharmaceutical Lisinopril Description and Business Overview
6.13.3 West Ward Pharmaceutical Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.13.4 West Ward Pharmaceutical Lisinopril Product Portfolio
6.13.5 West Ward Pharmaceutical Recent Developments/Updates
6.14 Wockhardt
6.14.1 Wockhardt Corporation Information
6.14.2 Wockhardt Lisinopril Description and Business Overview
6.14.3 Wockhardt Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.14.4 Wockhardt Lisinopril Product Portfolio
6.14.5 Wockhardt Recent Developments/Updates
6.15 Merck Research Laboratories
6.15.1 Merck Research Laboratories Corporation Information
6.15.2 Merck Research Laboratories Lisinopril Description and Business Overview
6.15.3 Merck Research Laboratories Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Merck Research Laboratories Lisinopril Product Portfolio
6.15.5 Merck Research Laboratories Recent Developments/Updates
6.16 Astrazeneca
6.16.1 Astrazeneca Corporation Information
6.16.2 Astrazeneca Lisinopril Description and Business Overview
6.16.3 Astrazeneca Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.16.4 Astrazeneca Lisinopril Product Portfolio
6.16.5 Astrazeneca Recent Developments/Updates
6.17 Alvogen
6.17.1 Alvogen Corporation Information
6.17.2 Alvogen Lisinopril Description and Business Overview
6.17.3 Alvogen Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Alvogen Lisinopril Product Portfolio
6.17.5 Alvogen Recent Developments/Updates
6.18 Hikma
6.18.1 Hikma Corporation Information
6.18.2 Hikma Lisinopril Description and Business Overview
6.18.3 Hikma Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Hikma Lisinopril Product Portfolio
6.18.5 Hikma Recent Developments/Updates
6.19 Prinston
6.19.1 Prinston Corporation Information
6.19.2 Prinston Lisinopril Description and Business Overview
6.19.3 Prinston Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Prinston Lisinopril Product Portfolio
6.19.5 Prinston Recent Developments/Updates
6.20 Accord Hlthcare
6.20.1 Accord Hlthcare Corporation Information
6.20.2 Accord Hlthcare Lisinopril Description and Business Overview
6.20.3 Accord Hlthcare Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Accord Hlthcare Lisinopril Product Portfolio
6.20.5 Accord Hlthcare Recent Developments/Updates
6.21 CASI Pharms
6.21.1 CASI Pharms Corporation Information
6.21.2 CASI Pharms Lisinopril Description and Business Overview
6.21.3 CASI Pharms Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.21.4 CASI Pharms Lisinopril Product Portfolio
6.21.5 CASI Pharms Recent Developments/Updates
6.22 Invagen Pharms
6.22.1 Invagen Pharms Corporation Information
6.22.2 Invagen Pharms Lisinopril Description and Business Overview
6.22.3 Invagen Pharms Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.22.4 Invagen Pharms Lisinopril Product Portfolio
6.22.5 Invagen Pharms Recent Developments/Updates
6.23 SUN Pharm
6.23.1 SUN Pharm Corporation Information
6.23.2 SUN Pharm Lisinopril Description and Business Overview
6.23.3 SUN Pharm Lisinopril Sales, Revenue and Gross Margin (2016-2021)
6.23.4 SUN Pharm Lisinopril Product Portfolio
6.23.5 SUN Pharm Recent Developments/Updates 7 Lisinopril Manufacturing Cost Analysis
7.1 Lisinopril Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Lisinopril
7.4 Lisinopril Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Lisinopril Distributors List
8.3 Lisinopril Customers 9 Lisinopril Market Dynamics
9.1 Lisinopril Industry Trends
9.2 Lisinopril Growth Drivers
9.3 Lisinopril Market Challenges
9.4 Lisinopril Market Restraints 10 Global Market Forecast
10.1 Lisinopril Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Lisinopril by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Lisinopril by Type (2022-2027)
10.2 Lisinopril Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Lisinopril by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Lisinopril by Application (2022-2027)
10.3 Lisinopril Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Lisinopril by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Lisinopril by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

Click Here To Place Your Order: https://www.qyresearch.com/settlement/pre/6fe44bd19bc33fd758eb8f962a00e1b4,0,1,global-lisinopril-market

 

Contact US:
QY Research, INC.
17890 Castleton,
Suite 218,
City of industry, CA – 91748
USA: +1 626 295 2442
Email: enquiry@qyresearch.com
Web: http://www.qyresearch.com

About Us:

 

QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), expert’s resources (included energy automotive chemical medical ICT consumer goods etc.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lisinopril Market Revenue facts statastics By 2027 | Actavis Elizabeth, Apotex, Aurobindo Pharma here

News-ID: 2514145 • Views: …

More Releases from QY Research, Inc

Global Lanolin Oil and Lanolin Wax Market Is Anticipated to Reach US$ million by 2029, growing at a CAGR of % During 2023-2029
Global Lanolin Oil and Lanolin Wax Market Is Anticipated to Reach US$ million by …
The global Lanolin Oil and Lanolin Wax market is carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Lanolin Oil and Lanolin Wax market. For instance, the market dynamics section digs deep into the drivers, restraints,…
Global Nafion Market Is Anticipated to Reach US$ 2314.3 million by 2029, growing at a CAGR of 7.4% During 2023-2029
Global Nafion Market Is Anticipated to Reach US$ 2314.3 million by 2029, growing …
Nafion is a copolymer of Teflon and perfluoro-3,6-diepoxy-4-methyl-7-decene-sulfuric acid. It also can be called as Perfluorosulfonic acid. The simple Nafion is a Teflon structure with another fluorocarbon temporary side chain. The end of the side chain is a sulfonic acid group (- SO3H). The global Nafion market size is expected to reach US$ 2314.3 million by 2029, growing at a CAGR of 7.4% from 2023 to 2029. The market is mainly…
Global Copper Chlorophyll Market Is Anticipated to Reach US$ 6552 million by 2029, growing at a CAGR of 1.7% During 2023-2029
Global Copper Chlorophyll Market Is Anticipated to Reach US$ 6552 million by 202 …
Copper chlorophyll is a kind of food coloring agents. It can be dissolved in the oil. The global Copper Chlorophyll market size is expected to reach US$ 6552 million by 2029, growing at a CAGR of 1.7% from 2023 to 2029. The market is mainly driven by the significant applications of Copper Chlorophyll in various end use industries. The expanding demands from the Food Industry, Drug Industry, Chemical Industry and Others,…
Global Copper Strips Market Is Anticipated to Reach US$ 21310 million by 2029, growing at a CAGR of 3.9% During 2023-2029
Global Copper Strips Market Is Anticipated to Reach US$ 21310 million by 2029, g …
Copper is a light metal with outstanding malleable and ductile properties. It possesses high thermal and electrical conductivity. It is widely used in numerous industrial and antibacterial applications high malleability property of copper and ease of application in machineries during fabrication procedures enables high production rate of precise copper strips at relatively lower cost as compared to its substitutes. The copper most commonly used for strip applications complies with ASTM B370.…

All 5 Releases


More Releases for Lisinopril

Lisinopril Tablets Market Size 2022, Profiles, Types and Application of Top Comp …
Los Angeles, United State: A newly published report titled "Global Itopride Hydrochloride API Market Research Report 2022" by QY Research throws light on the industry dynamics and current and future trends that play a key role in determining the business expansion. The Itopride Hydrochloride API report also highlights the key driving factors and restraints that are impacting the growth. For a comprehensive understanding, the professionals have reviewed the regulatory scenario,…
Angiotensin Converting Enzymes (ACE) Inhibitors Market Expected to Expand at a S …
Angiotensin converting enzymes inhibitors are used for the treatment of various medical conditions such as hypertension, coronary artery disease, heart failure, diabetes, chronic kidney diseases, scleroderma, and migraine. Frequently prescribed angiotensin converting enzyme (ACE) inhibitors include benazepril, perindopril, trandolapril, captopril, enalaopril, lisinopril, and ramipril. Moreover, ACE inhibitors are the first choice drugs by healthcare providers for the treatment of hypertension. The global angiotensin converting enzymes (ACE) inhibitors market was valued…
Congestive Heart Failure Drugs Market Witnesses Significant Growth Due to Increa …
The pharmaceutical industry has had a remarkable rise in sales of congestive heart failure drugs over the last five years. Products in the congestive heart failure drugs market include beta blockers (carvedilol, metoprolol, bisoprilol), ACE inhibitors (lisinopril, captopril), angiotensin receptor blockers (losartan), combination medicines (Entresto, or sacubitril/valsartan), aldosterone antagonist (spironolactone, eplerenone), and digoxin (Lanoxin). There has been a parallel increase in the number of individuals diagnosed with congestive heart failure.…
Myocardial Infarction Drugs Market to Achieve Top Growth with Rising CAGR
According to a new report published by Allied Market Research, titled, "Myocardial Infarction Drugs Market by Product Type (Analgesics, Antiplatelet Agents, Vasodilators, Thrombolytics, Anti-Thrombotic Agents, Glycoprotein IIb/IIIa Inhibitors, Î' Adrenergic Blockers, Angiotensin Receptor Blockers, and Angiotensin Converting Enzyme Inhibitors) and by Distribution Channel (Hospital Pharmacies, Hospitals, Drug Stores, and Online Drug Stores) - Global Opportunity Analysis and Industry Forecast, 2020-2027". The Global market size of Myocardial Infarction Drugs Market was $XX…
Angiotensin Converting Enzymes (ACE) Inhibitors Market Overview, Analysis, Growt …
Angiotensin converting enzymes (ACE) inhibitors act by inhibiting the angiotensin converting enzyme (ACE), which is an important component of renin angiotensin system. ACE inhibitors reduce the formation of angiotensin II and facilitate the dilation of blood vessels as well as reduce blood pressure. Angiotensin converting enzyme inhibitors also reduce blood pressure in kidneys. Angiotensin converting enzymes inhibitors (ACE) are effective for the treatment of congestive heart failure, stroke, and high…
Myocardial Infarction Drugs Market Key Players : Astrazeneca plc, Janssen Biotec …
Myocardial infarction, commonly known as heart attack, occurs due to reduced blood flow to a part of the heart, causing damage to the heart muscle. The medications, which are used to treat heart attacks are known as myocardial infarction drugs. The reduced blood flow further causes blockage in the supply of oxygen to the heart, which is due to atherosclerosis, a process in which the plaque is formed on the…